Interleukin-17 and interleukin-10 in the adenoid hypertrophy children concomitant with otitis media with effusion
Frontiers in Pharmacology · 07.04.2026 · 17
DOI: 10.3389/fphar.2026.1743884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.04.2026. Verfasst von Yuyan Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Healt…. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
Adenoid hypertrophy (AH) is a prevalent cause of otitis media with effusion (OME) in children, although its pathogenesis remains poorly understood. The objective of this study is to assess the levels of interleukin-17 (IL-17) and interleukin-10 (IL-10) in children with isolated AH and those with AH in conjunction with OME.
Methods
Thirty children with AH and OME who underwent adenoidectomy and tympanostomy tube placement were included in the OME group, whereas 30 children with isolated AH who underwent adenoidectomy were included in the AH group. Adenoid tissue samples were collected during surgery, and preoperative venous blood samples were acquired. Concentrations of IL-17 and IL-10 in both adenoid tissue and serum were measured using enzyme-linked immunosorbent assay (ELISA).
Results
Levels of IL-17 (4.20 ± 1.51 ng/mL) and IL-10 (3.77 ± 1.06 ng/mL) in adenoid tissue were significantly lower in the OME group than in the AH group (5.29 ± 2.16 ng/mL and 4.80 ± 1.93 ng/mL, respectively; P < 0.05). No significant differences in serum levels of IL-17 or IL-10 were observed between the two groups (P > 0.05). ROC analysis revealed that adenoid tissue IL-17 and IL-10 exhibited higher AUC values, specificity, and sensitivity for predicting AH in combination with OME compared to their serum counterparts (P < 0.05).
Conclusion
The reduced local expression of IL-17 and IL-10 in adenoid tissue is associated with the development of OME in children with AH. Targeting these cytokines may provide potential therapeutic strategies for preventing or treating AH-related OME.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.
Zitieren
APA
Yan, Y., Zuo, L., Wang, Y., Cui, L., Song, Y., Wang, L., Liu, X., Wang, H., & Geng, J. (2026). Interleukin-17 and interleukin-10 in the adenoid hypertrophy children concomitant with otitis media with effusion. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1743884
Vancouver
Yan Y, Zuo L, Wang Y, Cui L, Song Y, Wang L, et al. Interleukin-17 and interleukin-10 in the adenoid hypertrophy children concomitant with otitis media with effusion. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1743884
BibTeX
@article{Yan2026,
author = {Yan, Yuyan and Zuo, Lujie and Wang, Yafang and Cui, Li and Song, Yingluan and Wang, Li and Liu, Xiaofeng and Wang, Hongbo and Geng, Jiangqiao},
title = {Interleukin-17 and interleukin-10 in the adenoid hypertrophy children concomitant with otitis media with effusion},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1743884}
}
EUVIMED